More people in Quebec are using the abortion pill, experts say

Quebec reported a nearly 80% rise in reimbursed Mifegymiso prescriptions in 2025 (2,852 vs. 1,586 in 2024), and experts link the increase to eased 2022 restrictions, expanded prescribers and telemedicine.

Quebec reported a notable rise in use of the medication abortion drug Mifegymiso in 2025. Public insurance data from RAMQ showed 2,852 reimbursed prescriptions last year, up from 1,586 in 2024. The province removed several prescribing requirements in 2022 and later announced a plan aimed at improving access, information and research. Health experts and family-planning groups say broader prescribing authority, telemedicine and clearer information have contributed to the increase. Key facts: - RAMQ data show 2,852 reimbursed Mifegymiso prescriptions in 2025 versus 1,586 in 2024, an increase of nearly 80%. - Quebec eased a series of restrictions in 2022 that had limited who could prescribe medication abortion. - Doctors, specialized nurse practitioners and midwives can now prescribe the pill, and it can be offered in some cases via telemedicine. - In 2024 the provincial plan announced by the then-minister included 28 measures focused on regional access, combating misinformation, contraception information and research. - Experts say the rise in medication use does not necessarily mean overall abortion rates increased; they note safety, accessibility and reports of some clinics adjusting procedural abortion schedules. Summary: The reported increase follows policy changes, expanded prescriber roles and greater availability of information, and has coincided with higher use of medication abortion in Quebec. Observers note the shift has affected how abortions are delivered, including more home-based medication options and some changes to procedural services. Undetermined at this time.